Haleon Crecimiento futuro
Future controles de criterios 1/6
Haleon is forecast to grow earnings and revenue by 10.6% and 3.8% per annum respectively. EPS is expected to grow by 13% per annum. Return on equity is forecast to be 9.5% in 3 years.
Información clave
10.6%
Tasa de crecimiento de los beneficios
13.0%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Personal Products | 25.3% |
| Tasa de crecimiento de los ingresos | 3.8% |
| Rentabilidad financiera futura | 9.5% |
| Cobertura de analistas | Good |
| Última actualización | 04 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Haleon: Tailwinds Are Mostly Priced In
Oct 24Haleon: Defensive Consumer Healthcare Stock As Safe Haven
Aug 06The Investment Case For Haleon: Steady Shareholder Value Accumulation
Nov 20The Share Price Has The Flu, But Haleon Is As Healthy As An Ox
Sep 07Haleon: A Hidden Gem In The Consumer Health Market
Jun 12Haleon exploring sale of ChapStick Brand - report
Feb 25Haleon said to evaluate potential deals to increase its size - report
Jan 31Haleon: Undervalued With Clear Catalyst Ahead
Aug 31Former GSK consumer health unit Haleon hits all-time low
Aug 19Haleon CEO says brand recognition, gross margins will drive growth - CNBC
Jul 20Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 11,996 | 1,813 | 1,892 | N/A | 13 |
| 12/31/2025 | 11,483 | 1,664 | 1,780 | N/A | 16 |
| 12/31/2024 | 11,222 | 1,487 | 1,642 | N/A | 15 |
| 9/30/2024 | 11,240 | 1,208 | N/A | N/A | N/A |
| 6/30/2024 | 11,258 | 1,088 | 2,455 | 2,193 | N/A |
| 3/31/2024 | 11,235 | 1,083 | N/A | N/A | N/A |
| 12/31/2023 | 11,302 | 1,049 | 2,010 | 2,100 | N/A |
| 9/30/2023 | 11,314 | 1,250 | N/A | N/A | N/A |
| 6/30/2023 | 11,408 | 1,230 | 1,796 | 2,132 | N/A |
| 3/31/2023 | 11,217 | 1,106 | N/A | N/A | N/A |
| 12/31/2022 | 10,858 | 1,060 | 1,771 | 2,063 | N/A |
| 9/30/2022 | 10,560 | 1,390 | N/A | N/A | N/A |
| 6/30/2022 | 10,158 | 1,416 | 1,604 | 1,802 | N/A |
| 3/31/2022 | 9,866 | 1,500 | N/A | N/A | N/A |
| 12/31/2021 | 9,545 | 1,390 | 1,195 | 1,356 | N/A |
| 12/31/2020 | 9,892 | 1,145 | 2,013 | 1,407 | N/A |
| 12/31/2019 | 8,480 | 655 | 663 | 786 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: HLN's forecast earnings growth (10.6% per year) is above the savings rate (2.5%).
Beneficios vs. Mercado: HLN's earnings (10.6% per year) are forecast to grow slower than the US market (15.4% per year).
Beneficios de alto crecimiento: HLN's earnings are forecast to grow, but not significantly.
Ingresos vs. Mercado: HLN's revenue (3.8% per year) is forecast to grow slower than the US market (8.9% per year).
Ingresos de alto crecimiento: HLN's revenue (3.8% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: HLN's Return on Equity is forecast to be low in 3 years time (9.5%).